HC Deb 14 January 2004 vol 416 cc805-6W
Mr. Charles Kennedy

To ask the Secretary of State for Health what clinical trials have been conducted to establish the effectiveness of potassium iodate tablets in minimising the effects resulting from inhalation of airborne radioactive iodine, with particular reference to prevention of thyroid cancer; and if he will make a statement. [147205]

Dr. John Reid

Stable iodine (of which potassium iodate is only one form) has been used clinically since the 1940s to protect the thyroid glands of patients (both children and adults) being treated with radio-pharmaceuticals which contain radioactive iodine. Potassium iodate is still routinely used in this way to this day. Its efficacy at protecting against the radiation induced thyroid cancer has been known, therefore, for over 60 years. The largest population administration occurred in Poland following the Chernobyl accident where over 9 million doses were administered. No adverse effects were reported and no increase in the rate of thyroid cancer was subsequently seen, unlike in Belorus and Ukraine were stable iodine was not administered to protect the local population.